AP-017 (Anyuan Pharmaceutical Technology)

N/A

Report date: 2025/01/26 18:39:28

Base Information

Drug NameAP-017 (Anyuan Pharmaceutical Technology)
Drug Alias Namemonoclonal antibody (Anuyan Pharmaceutical Technology)AP-017 (Anyuan Pharmaceutical Technology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionBlood clotting modulators
TargetsUpdating
Therapy Area/IndicationsHemophilia BHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Anyuan Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Anyuan Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia BHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A